Tradestie Institutional Equity Comparison Engine

RBOT.WS vs ISRG โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-20 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

ISRG Overall Edge

ISRG Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Intuitive Surgical Inc. (ISRG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, RBOT.WS trades at N/M Forward P/E with N/A operating margin (N/A YoY revenue) versus ISRG at 32.0x Forward P/E and 31.7% operating margin (+21.7% YoY). In options structure, RBOT.WS sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against ISRG sits in SURGE (69th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner ISRG
RBOT.WS N/M vs ISRG 32.0x Fwd P/E
Growth & Margin Winner ISRG
Op Margin N/A vs 31.7% ยท YoY N/A vs +21.7%
Momentum & Technical Winner ISRG
1Y -67.2% vs -29.3% ยท 52W Pos 0% vs 26%
Options & Structure Winner ISRG
UNCLASSIFIED (N/A IV) vs SURGE (69th %ile IV)
RBOT.WS NYSE
Vicarious Surgical Inc. Warrants, each whole warrant exercisable for 1/30th of a share of Class A Common Stock at an exercise price of $345.00
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$0.01
-24.77% 1D
Market Cap N/A
1M Return -67.2%
1Y Return -67.2%
Forward P/E N/M
Unified AI Score
50.1 / 100 HOLD
Tech 40.0 Fund 46.0 Flow 50.0 Mom 50.0
ISRG NASDAQ
Intuitive Surgical Inc.
Orthopedic, Prosthetic & Surgical Appliances & Supplies
$399.05
-2.01% 1D
Market Cap $141.2B
1M Return -10.09%
1Y Return -29.33%
Forward P/E 32.0x
Unified AI Score
43.8 / 100 HOLD
Tech 32.0 Fund 47.0 Flow 58.0 Mom 56.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: RBOT.WS -67.2% ISRG -29.33% Spread: +68.5 pp (ISRG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
RBOT.WS TTM Op. Margin: N/A ISRG TTM Op. Margin: 31.7%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on RBOT.WS vs ISRG. Trailing 12-month operating profitability (RBOT.WS N/A vs ISRG 31.7%) and valuation multiples (RBOT.WS N/M vs ISRG 32.0x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: RBOT.WS (1) vs ISRG (9)
Institutional Metric RBOT.WS ISRG Criterion Row Winner
Market Capitalization Scale N/A $141.2B Larger Scale ISRG
Trailing P/E Ratio Valuation N/M 49.2x Lower Multiple ISRG
Forward P/E Ratio Valuation N/M 32.0x Lower Multiple ISRG
Revenue Growth (YoY) Growth N/A +21.7% Higher Growth ISRG
Operating Margin (TTM) Profitability N/A 31.7% Higher Margin ISRG
Net Profit Margin Profitability N/A 25.5% Higher Margin ISRG
Return on Equity (ROE) Capital Efficiency N/A 17.9% Higher ROE ISRG
52-Week Range Position Momentum 0% ($0โ€“$0) 26% ($329โ€“$604) Stronger Trend ISRG
Beta / 30D Volatility Risk Regime N/A 0.81ฮฒ ยท 44% Vol Lower Realized Risk ISRG
Unified Institutional Score Composite Signal 50.1 / 100 (HOLD) 43.8 / 100 (HOLD) Higher Composite RBOT.WS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full RBOT.WS vs ISRG Buy Guide
RBOT.WS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live RBOT.WS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
ISRG SURGE
12d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 69th %ile
IV Regime Elevated (60thโ€“80th %ile)
Live ISRG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither RBOT.WS nor ISRG registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.